Epilepsy & Seizures
Ambiguous paroxysmal events
Mar. 22, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
01.14.2025
Developmental regression in children is a complex and concerning phenomenon that demands attention from clinicians across various specialties. This overview aims to provide insights into this critical topic, highlighting recent advancements and addressing controversies in the field.
Developmental regression occurs when a child loses previously acquired language, motor function, and social interaction skills. It has been defined as the loss of acquired skills not caused by brain injury or other traumatic events. This phenomenon is often associated with genetic or neurodevelopmental disorders, progressive neurodegenerative conditions, or developmental epileptic encephalopathy. The challenges in understanding the causes of developmental regression are complicated by biological complexity and methodological limitations, such as the absence of a universally accepted definition.
Neurodevelopmental disorders and genetic syndromes. Developmental regression may be an early feature of a neurodevelopmental condition, such as autism spectrum disorder or childhood disintegrative disorder. Children with autism spectrum disorder show developmental regression, especially in social communication, language skills, and repetitive behaviors often observed between the ages of 1 and 3 years. Clinical features in childhood disintegrative disorder are characterized by the loss of developmental and adaptive skills, along with the presence of autistic features, in a child who exhibited typical development for at least the first 2 years of life.
Conditions like Rett syndrome and Phelan-McDermid syndrome also feature developmental regression. In Phelan-McDermid syndrome, regression often begins in mid-childhood, primarily affecting language skills, followed by motor and psychosocial abilities.
Neurodegenerative disorders. Among these conditions are Batten disease and Niemann-Pick, which present progressive loss of skills, including vision, motor, and cognitive functions, as the nervous system deteriorates.
Developmental epileptic encephalopathy. Developmental epileptic encephalopathy encompasses various conditions, including Landau-Kleffner syndrome and continuous slow wave sleep disorder, among others. These disorders present developmental challenges, including epileptic seizures, and may also lead to cognitive and behavioral impairments. The features of regression are influenced not only by epileptic activity but also by the underlying causes. In most cases of developmental epileptic encephalopathy, the altered development is primarily linked to neurobiological factors rather than the frequency of seizures or the presence of epileptiform activity.
A multidisciplinary approach is crucial in managing developmental regression. Key components include:
Genetic testing. Advances in genetic testing have improved our ability to identify underlying causes of regression. However, interpreting genetic variants remains challenging, often leading to inconclusive results.
Biomarkers. Research into biomarkers for early detection of regression is promising but controversial. The ethical implications of early identification are debated, especially in conditions without curative treatments.
Therapeutic approaches. While early intervention is widely accepted as beneficial, the optimal intensity and duration of therapies remain controversial. Some argue for intensive interventions, while others advocate for more naturalistic approaches.
Developmental regression in children remains a challenging area in pediatric neurology. However, by staying informed about the latest research, we can be better prepared to address the complex needs of affected children and their families. Early identification and intervention are crucial for improving outcomes, and as clinicians, our commitment to this field is key.
Are you interested in being a guest blogger for MedLink Neurology? Contact us at editorial@medlink.com.
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125